Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 55Unknown 8Terminated 6Recruiting 5Withdrawn 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Vitamin D × Clear all
NCT00482157 2022-03-03

Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance

Stanford University

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT01956864 2018-02-01

Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer

Johns Hopkins University

Phase 1 Withdrawn
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡